The participants in the trial – similar to two-thirds of breast cancer patients overall - had tumors that use the hormones estrogen and progesterone to grow. The goal of so-called endocrine therapy is ...

The EMA has lifted restrictions on the chikungunya vaccine in people 65 and older, while warning that it should be used only ...

Controversial precautionary rules imposed last year for prescribing valproate to potentially fertile males are being assessed ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 ...

Valneva (NASDAQ:VALN) said on Friday that the European Medicines Agency (EMA) has lifted the suspension on its chikungunya ...

The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

Vertex Pharmaceuticals secured European approval for Alyftrek, reinforcing its dominance in cystic fibrosis treatment as ...

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

Novo Nordisk A/S (NYSE:NVO) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 23, Novo Nordisk A ...

Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...

The server encountered an error and could not complete your request. If the problem persists, please contact us using the ...